CIK 0001022079
DGX QUEST DIAGNOSTICS INC
Insider trading from SEC Form 4. Last filing Dec 2, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company
Signals
Open-market buys and sells at QUEST DIAGNOSTICS INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 15Weak | sell10b5-1 | Doherty Catherine T. EVP, Regional Businesses | $5.4M | 33,103 | -33% | - | |
| 23Weak | sell 210b5-1 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | $2.9M | 18,755 | -35% | - | |
| 42Moderate | sell 2 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | $279k | 1,775 | -15% | - |
Congressional trades
9 trades in DGX disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Carol D. Miller House · R-WV | Sale | DGX Quest Diagnostics Incorporated Common Stock | $15k to $50k | Mar 10, 2025 | 521 days after the trade |
| Julie Johnson House · D-TX | Sale | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Oct 30, 2025 | 279 days after the trade |
| Julie Johnson House · D-TX | Purchase | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Oct 30, 2025 | 279 days after the trade |
| Alan Armstrong Senate · R-OK | Purchase | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Mar 30, 2026 | 113 days after the trade |
| Alan Armstrong Senate · R-OK | Purchase | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| Julia Letlow House · R-LA | Purchase | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Apr 28, 2025 | 260 days after the trade |
| Julia Letlow House · R-LA | Sale | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Jul 24, 2025 | 173 days after the trade |
| Julie Johnson House · D-TX | Sale | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Nov 3, 2025 | 38 days after the trade |
| Carol D. Miller House · R-WV | Sale | DGX Quest Diagnostics Incorporated Common Stock | $1,001 to $15k | Mar 10, 2025 | 32 days after the trade |
Transactions
The last 18 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Doherty Catherine T. EVP, Regional Businesses | MOption exercise Common Stock10b5-1 | +33,103 | $103.57 | $3.4M | 101,515 | Dec 2, 2024 |
| Nov 27, 2024 | Doherty Catherine T. EVP, Regional Businesses | SOpen-market sale Common Stock10b5-1 | -4,803 | $162.14 | $779k | 96,712 | Dec 2, 2024 |
| Nov 27, 2024 | Doherty Catherine T. EVP, Regional Businesses | SOpen-market sale Common Stock10b5-1 | -28,300 | $163.13 | $4.6M | 68,412 | Dec 2, 2024 |
| Nov 27, 2024 | Doherty Catherine T. EVP, Regional Businesses | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -33,103 | $103.57 | $3.4M | 0 | Dec 2, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | MOption exercise Common Stock10b5-1 | +8,635 | $71.17 | $615k | 43,576 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | MOption exercise Common Stock10b5-1 | +10,120 | $66.51 | $673k | 53,696 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | SOpen-market sale Common Stock10b5-1 | -2,100 | $152.70 | $321k | 51,596 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | SOpen-market sale Common Stock10b5-1 | -2,400 | $153.98 | $370k | 49,196 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | SOpen-market sale Common Stock10b5-1 | -4,135 | $154.74 | $640k | 45,061 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | SOpen-market sale Common Stock10b5-1 | -2,600 | $152.71 | $397k | 42,461 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | SOpen-market sale Common Stock10b5-1 | -2,331 | $154.03 | $359k | 40,130 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | SOpen-market sale Common Stock10b5-1 | -5,189 | $154.74 | $803k | 34,941 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -8,635 | $71.17 | $615k | 0 | Nov 7, 2024 |
| Nov 6, 2024 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -10,120 | $66.51 | $673k | 0 | Nov 7, 2024 |
| Oct 28, 2024 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | SOpen-market sale Common Stock | -1,775 | $156.92 | $279k | 9,734 | Oct 30, 2024 |
| Oct 21, 2024 | DELANEY MARK E SVP & Chief Commercial Officer | LSmall acquisition Common Stock | +4 | $149.39 | $598 | 5,023 | Oct 25, 2024 |
| Oct 21, 2024 | Gregg Vicky B director | LSmall acquisition Common Stock | +76 | $149.37 | $11k | 18,045 | Oct 25, 2024 |
| Oct 21, 2024 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | LSmall acquisition Common Stock | +21 | $149.37 | $3,137 | 11,509 | Oct 25, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- DELANEY MARK ESVP & Chief Commercial Officer
- DEPPE MICHAEL JSVP, Corp. Controller & CAO
- Doherty Catherine T.EVP, Regional Businesses
- Gregg Vicky Bdirector
- KUPPUSAMY KARTHIKSVP, Clinical Solutions
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.